供应NIBSC20/292可溯源凝血八因子国际标准物质
产品详情如下，更多产品价格和货期，请咨询客服！
世界卫生组织第二份凝血因子XIII（FXIII）血浆国际标准由编号为20/292的安瓿组成，安瓿中含有等分的含有FXIII的冻干人血浆。该制剂由世界卫生组织生物标准化专家委员会（ECBS）于2022年10月建立（1）。 NIBSC20/292
本标准旨在用于测量血浆中FXIII的活性和抗原（A2B2复合物和总FXIII-B亚基），主要用于二级和/或内部工作的FXIII血浆标准的愈伤组织。
The WHO 2nd International Standard for Blood Coagulation Factor XIII (FXIII) Plasma consists of ampoules, coded 20/292,containing aliquots of a freeze-dried human plasma containing FXIII. This preparation was established by the Expert Committee on Biological Standardization (ECBS) of the World Health Organization in October 2022 (1). This standard is intended to be used in the measurement of FXIII,both activity and antigen (A2B2 complex & Total FXIII-B subunit),in plasma and is primarily intended for callibration of secondary and/or in-house working FXIII plasma standards. 可溯源凝血八因子国际标准物质
部分相关产品如下，更多相关产品的详细信息，请咨询客服，仅供实验室使用。
Related Product
08/214 Meningococcal Serogroup C polysaccharide 脑膜炎球菌C群多糖
08/218 Tetanus Toxoid Adsorbed 吸附破伤风类毒素
08/230 Streptodornase 链球菌酶
08/256 C1- Inhibitor, Concentrate C1-抑制剂，浓缩物
08/258 Antithrombin, Plasma 抗凝血酶，血浆/血浆中抗凝血酶
08/262 C1 Inhibitor (Plasma) C1抑制剂（血浆）/血浆中C1抑制剂
08/266 Sex Hormone Binding Globulin 性激素结合球蛋白